Expected headings
"Cervical lymph nodes"
"Mediastinal lymph nodes"
"Mesenteric lymph nodes"
"Lymphadenopathy (or adenopathy) is, if anything, a broader term than lymph node enlargement, referring to any pathology of lymph nodes, not necessarily resulting in increased size; this includes an abnormal number of nodes or derangement of internal architecture (e.g. cystic or necrotic nodes). In addition, an increase in size is not always pathologic; some nodes are bigger than others normally (e.g. cf. jugulodigastric nodes with mesenteric nodes), and reactive nodes are a healthy response and do not imply pathology of the node itself."
"Lymphadenopathy (or adenopathy) is, if anything, a broader term than lymph node enlargement, referring to any pathology of lymph nodes, not necessarily resulting in increased size; this includes an abnormal number of nodes or derangement of internal architecture (e.g. cystic or necrotic nodes). In addition, an increase in size is not always pathologic; some nodes are bigger than others normally (e.g. cf. jugulodigastric nodes with mesenteric nodes), and reactive nodes are a healthy response and do not imply pathology of the node itself."
"There are approximately 600 lymph nodes, of which only some are available to direct palpation. Only some nodes (including neck, axilla and groin) should ever be normally palpable, and when they are, they should be soft and non-tender."
"There are many causes of lymph node enlargement, which include:"
"There are approximately 600 lymph nodes, of which only some are available to direct palpation. Only some nodes (including neck, axilla and groin) should ever be normally palpable, and when they are, they should be soft and non-tender."
"In general, 10 or 15 mm is considered the upper limit for normal nodes (short axis diameter) depending on the clinical scenario 3-5,10. This does not, of course, take into consideration the fact that all nodal metastases must start at microscopic size, and thus using only size criteria will miss micrometastases. In the setting of lung cancer staging a sensitivity of 0.83 and a specificity of 0.82 are quoted for CT 5."